Publications by authors named "Bill Bosch"

Claim this Profile
R
Randomized phase 2 therapeutic equivalence study of abiraterone acetate fine particle formulation vs. originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer: The STAAR study.
Cy A Stein, Richard Levin, Robert Given, Celestia S Higano, Paul Nemeth, Bill Bosch

Urol Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of an alternative steroid on the relative bioavailability and bioequivalence of a novel versus the originator formulation of abiraterone acetate.
Azra Hussaini, Anthony J Olszanski, Cy A Stein, Bill Bosch, Paul Nemeth

Cancer Chemother Pharmacol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of a Novel Formulation of Abiraterone Acetate vs. the Originator Formulation in Healthy Male Subjects: Two Randomized, Open-Label, Crossover Studies.
Ronald Goldwater, Azra Hussaini, Bill Bosch, Paul Nemeth

Clin Pharmacokinet· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology.
Roy Altman, Bill Bosch, Kay Brune, Paola Patrignani, Clarence Young

Drugs· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis